vs
Side-by-side financial comparison of AvalonBay Communities (AVB) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
AvalonBay Communities is the larger business by last-quarter revenue ($767.9M vs $622.0M, roughly 1.2× Royalty Pharma plc). AvalonBay Communities runs the higher net margin — 9040.6% vs 34.4%, a 9006.1% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 3.7%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 3.8%).
AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
AVB vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $767.9M | $622.0M |
| Net Profit | $166.0M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 64.2% | 62.4% |
| Net Margin | 9040.6% | 34.4% |
| Revenue YoY | 3.7% | 4.8% |
| Net Profit YoY | -41.2% | 2.9% |
| EPS (diluted) | $1.18 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $767.9M | $622.0M | ||
| Q3 25 | $766.8M | $609.3M | ||
| Q2 25 | $760.2M | $578.7M | ||
| Q1 25 | $745.9M | $568.2M | ||
| Q4 24 | $740.5M | $593.6M | ||
| Q3 24 | $734.3M | $564.7M | ||
| Q2 24 | $726.0M | $537.3M | ||
| Q1 24 | $712.9M | $568.0M |
| Q4 25 | $166.0M | $214.2M | ||
| Q3 25 | $381.3M | $288.2M | ||
| Q2 25 | $268.7M | $30.2M | ||
| Q1 25 | $236.6M | $238.3M | ||
| Q4 24 | $282.1M | $208.2M | ||
| Q3 24 | $372.5M | $544.0M | ||
| Q2 24 | $253.9M | $102.0M | ||
| Q1 24 | $173.4M | $4.8M |
| Q4 25 | 64.2% | 62.4% | ||
| Q3 25 | 65.7% | 70.1% | ||
| Q2 25 | 67.6% | 36.3% | ||
| Q1 25 | 68.5% | 94.0% | ||
| Q4 24 | 63.1% | 60.9% | ||
| Q3 24 | 65.4% | — | ||
| Q2 24 | 66.6% | 50.2% | ||
| Q1 24 | 67.2% | -13.0% |
| Q4 25 | 9040.6% | 34.4% | ||
| Q3 25 | 49.7% | 47.3% | ||
| Q2 25 | 35.3% | 5.2% | ||
| Q1 25 | 31.7% | 41.9% | ||
| Q4 24 | 38.1% | 35.1% | ||
| Q3 24 | 50.7% | 96.3% | ||
| Q2 24 | 35.0% | 19.0% | ||
| Q1 24 | 24.3% | 0.8% |
| Q4 25 | $1.18 | $0.49 | ||
| Q3 25 | $2.68 | $0.67 | ||
| Q2 25 | $1.88 | $0.07 | ||
| Q1 25 | $1.66 | $0.55 | ||
| Q4 24 | $1.99 | $0.46 | ||
| Q3 24 | $2.61 | $1.21 | ||
| Q2 24 | $1.78 | $0.23 | ||
| Q1 24 | $1.22 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | $618.7M |
| Total DebtLower is stronger | $9.3B | $9.0B |
| Stockholders' EquityBook value | $11.6B | $9.7B |
| Total Assets | $22.2B | $19.6B |
| Debt / EquityLower = less leverage | 0.80× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | $618.7M | ||
| Q3 25 | $123.3M | $938.9M | ||
| Q2 25 | $102.8M | $631.9M | ||
| Q1 25 | $53.3M | $1.1B | ||
| Q4 24 | $108.6M | $929.0M | ||
| Q3 24 | $552.4M | $950.1M | ||
| Q2 24 | $545.8M | $1.8B | ||
| Q1 24 | $287.9M | $843.0M |
| Q4 25 | $9.3B | $9.0B | ||
| Q3 25 | $8.7B | $8.9B | ||
| Q2 25 | $8.7B | $8.0B | ||
| Q1 25 | $8.3B | $7.6B | ||
| Q4 24 | $8.1B | $7.6B | ||
| Q3 24 | $8.4B | $7.6B | ||
| Q2 24 | $8.4B | $7.6B | ||
| Q1 24 | $8.0B | $6.1B |
| Q4 25 | $11.6B | $9.7B | ||
| Q3 25 | $11.9B | $9.6B | ||
| Q2 25 | $11.9B | $9.5B | ||
| Q1 25 | $11.9B | $9.8B | ||
| Q4 24 | $11.9B | $10.3B | ||
| Q3 24 | $11.9B | $10.3B | ||
| Q2 24 | $11.7B | $9.8B | ||
| Q1 24 | $11.7B | $9.9B |
| Q4 25 | $22.2B | $19.6B | ||
| Q3 25 | $21.9B | $19.3B | ||
| Q2 25 | $21.8B | $18.3B | ||
| Q1 25 | $21.2B | $17.6B | ||
| Q4 24 | $21.0B | $18.2B | ||
| Q3 24 | $21.3B | $18.0B | ||
| Q2 24 | $21.0B | $17.7B | ||
| Q1 24 | $20.6B | $16.1B |
| Q4 25 | 0.80× | 0.92× | ||
| Q3 25 | 0.73× | 0.93× | ||
| Q2 25 | 0.72× | 0.84× | ||
| Q1 25 | 0.70× | 0.78× | ||
| Q4 24 | 0.68× | 0.74× | ||
| Q3 24 | 0.70× | 0.74× | ||
| Q2 24 | 0.71× | 0.78× | ||
| Q1 24 | 0.68× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7B | $827.1M |
| Free Cash FlowOCF − Capex | $1.4B | — |
| FCF MarginFCF / Revenue | 183.5% | — |
| Capex IntensityCapex / Revenue | 34.1% | — |
| Cash ConversionOCF / Net Profit | 10.07× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $827.1M | ||
| Q3 25 | $477.0M | $702.6M | ||
| Q2 25 | $377.8M | $364.0M | ||
| Q1 25 | $415.9M | $596.1M | ||
| Q4 24 | $1.6B | $742.5M | ||
| Q3 24 | $486.2M | $703.6M | ||
| Q2 24 | $380.0M | $658.2M | ||
| Q1 24 | $412.9M | $664.6M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $402.2M | — | ||
| Q2 25 | $317.1M | — | ||
| Q1 25 | $367.5M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $434.2M | — | ||
| Q2 24 | $333.0M | — | ||
| Q1 24 | $375.4M | — |
| Q4 25 | 183.5% | — | ||
| Q3 25 | 52.5% | — | ||
| Q2 25 | 41.7% | — | ||
| Q1 25 | 49.3% | — | ||
| Q4 24 | 191.0% | — | ||
| Q3 24 | 59.1% | — | ||
| Q2 24 | 45.9% | — | ||
| Q1 24 | 52.7% | — |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 6.5% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | 10.07× | 3.86× | ||
| Q3 25 | 1.25× | 2.44× | ||
| Q2 25 | 1.41× | 12.06× | ||
| Q1 25 | 1.76× | 2.50× | ||
| Q4 24 | 5.70× | 3.57× | ||
| Q3 24 | 1.31× | 1.29× | ||
| Q2 24 | 1.50× | 6.45× | ||
| Q1 24 | 2.38× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVB
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
